Articles by Editor
GlaxoSmithKline, Vir Biotech Team Up in Hunt For Coronavirus Treatment
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease caused by the coronavirus.As part of the collaboration agreement GSK will make an investment in Vir of $250 million, priced at $37.73, representing a 10% premium to the closing share price on March 27, 2020, according to the announcement. Vir’s shares soared as much as 34% rising to around $39 in early U.S. trading following the news of GSK’s investment.Wall Street analysts take a cautious stance on Vir’s stock. The Hold analyst consensus rating is based on …read more […]
This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section. Although, according to one analyst, if recent developments are anything to go by, the Beverly Hills, California based company won’t be in the small fry category for much longer.H.C. Wainwright’s Joseph Pantginis reiterated a Buy on Capricor along with a $9.00 price target. The implication for investors? Potential upside of a humungous 737%. (To watch Pantginis’s track record, click here)So, what is driving an analyst to set such an extravagant target for such a tiny player? Well, among …read more […]
'This is blood money': Amazon warehouse workers stage second walkout over coronavirus fears
On Monday, workers at an Amazon warehouse in Staten Island walked off the job for a second time, just one week after holding an initial strike, citing continued coronavirus fears amid 26 cases of the virus at the warehouse. …read more […]
Stocks jump as virus deaths slow; oil falls after OPEC+ delay
World stock markets jumped on Monday, encouraged by a slowdown in coronavirus-related deaths and new cases in some global hot spots, oil prices tumbled again due to a delay in talks between Saudi Arabia and Russia to cut supply.
Honda, Fiat Chrysler cancel all April U.S., Canadian auto production
Honda Motor Co and Fiat Chrysler Automobiles NV said on Monday they will extend their auto production shutdown in the United States and Canada to all of April.
Zoom competitor 8×8 sees spike in usage amid coronavirus
8×8 CEO Vik Verma joins Yahoo Finance’s Seana Smith to discuss the company’s increase in usage amid the COVID-19 pandemic, as Zoom encounters concerns over its security and privacy. …read more […]
New York, New Jersey see early signs of coronavirus ‘flattening’
The governors of New York and New Jersey said on Monday their states were showing tentative signs of a “flattening” of the coronavirus outbreak, but they warned against complacency as the nationwide death toll topped 10,000 and the number of cases reached 350,000.
Coronavirus muddies U.S. economic data as business closures push down response rates
A near total closure of U.S. businesses as authorities try to control the spread of the novel coronavirus could make U.S. economic data unreliable in the coming months and harder to get a clearer picture of the severity of the recession caused by the virus.
NYSE in talks with SEC to ease listing rules during coronavirus volatility
The New York Stock Exchange said on Monday it was in talks with regulators to temporarily ease its listing requirements to take the strain off companies that may have fallen out of compliance due to the market rout spurred by the coronavirus.
Airbus announces additional production pauses
Airbus said on Monday it had decided additional production pauses, in Germany and in the United States, in response to an industry-wide slowdown triggered by the coronavirus crisis.
Alaska’s RavnAir bankruptcy while awaiting government aid shows regional airlines’ challenges
RavnAir Group, the largest regional carrier in Alaska, filed for bankruptcy on Sunday and grounded all of its 72 planes, saying it was clear that government aid would not arrive before it ran out of cash in the midst of an “astonishing” decline in bookings and revenue due to the coronavirus.
Wall Street surges on hopes of slowing coronavirus deaths
U.S. stocks surged on Monday, with each of the major indexes rallying more than 5%, after a drop in the daily death toll in New York, the country’s biggest coronavirus hot spot, fueled hopes a leveling off of the pandemic was on the horizon.
Options Volume Runs High on Controversial Coffee Chain
Overall options volume is pacing in the 99th annual percentile today …read more […]
Coronavirus Fighter Gilead Sciences Might Be Expensive, but It’s Still Worth Owning
Gilead Sciences (GILD) has positioned itself at the front line in the global war against COVID-19. The biotech’s experimental drug remdesivir is currently in two Gilead sponsored Phase 3 trials in over 90 locations, and two further investigator sponsored Phase 3 trials in China. The drug is currently registered in 11 ongoing trials, from which a handful of data readouts are expected in the next 2 to 6 weeks.So far, remdesivir has shown powerful in vitro efficacy against RNA viruses in cell-based assays and evidence of efficacy in both in California and Washington states; Additionally, there has also been some …read more […]
